An overview of dengue viral infection circulating in Pakistan

J Vector Borne Dis. 2022 Apr-Jun;59(2):109-114. doi: 10.4103/0972-9062.331412.

Abstract

Background & objectives: Dengue virus (DENV) is an RNA virus that infects approximately 2.5 billion people around the world. The incidence of dengue fever has rapidly increased at an alarming rate in the last few years and has affected thousands of people in Pakistan. This review explores the prevalence, serotypes and pathogenesis of dengue virus circulating in Pakistan.

Methods: A systematic review of observational studies published between 1994 and December 2019 was performed. All records of the confirmed outbreak of dengue fever in Pakistan were reviewed and articles containing no primary data were excluded.

Results: Four identified serotypes of dengue virus (DENV 1-4) circulate in different regions of the world causing epidemics. The most prevalent serotype, which is still epidemic and dominant in Pakistan, is DENV-2. Many factors like over-population, rapid urbanization, travelling, lack of vector control in dengue endemic areas and inadequate health-care are responsible of dynamic and huge raise of dengue in Pakistan.

Interpretation & conclusion: Currently there is no specific treatment for prevention of dengue virus. Recently some antiviral compounds were being tested to eradicate this disease. There is a need to develop an efficient and safe vaccine for all four serotypes to combat dengue viral infection globally and particularly in Pakistan.

Keywords: Dengue virus; Non-structural proteins; Pathogenesis; Prevalence; Serotypes.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Antiviral Agents
  • Dengue Virus* / genetics
  • Dengue* / epidemiology
  • Dengue* / prevention & control
  • Humans
  • Pakistan / epidemiology
  • Serogroup

Substances

  • Antiviral Agents